Open AccessLong-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report
Author(s) -
Mariacristina Di Marco,
Riccardo Carloni,
Stefania De Lorenzo,
Elisa Grassi,
Andrea Palloni,
Francesca Formica,
Stefano Brocchi,
Daria Maria Filippini,
Rita Golfieri,
Giovanni Brandi
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i7.1241
Subject(s) - medicine , gemcitabine , capecitabine , radiofrequency ablation , oxaliplatin , pancreatic cancer , chemotherapy , oncology , surgery , progressive disease , gastroenterology , cancer , ablation , colorectal cancer
Pancreatic acinar cell carcinoma (PACC) is a rare type of malignant pancreatic cancer that represents approximately 1% of all pancreatic neoplasms. Due to its very low incidence, only a few retrospective studies are available. Although surgery is the first choice for treatment, most patients experience recurrence (mainly in the liver) and there are no clear recommendations for patients with advanced disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom